These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31371146)

  • 41. Diagnosis and Management of Type 1 Sialidosis: Clinical Insights from Long-Term Care of Four Unrelated Patients.
    Coppola A; Ianniciello M; Vanli-Yavuz EN; Rossi S; Simonelli F; Castellotti B; Esposito M; Tozza S; Troisi S; Bellofatto M; Ugga L; Striano S; D'Amico A; Baykan B; Striano P; Bilo L
    Brain Sci; 2020 Aug; 10(8):. PubMed ID: 32752208
    [No Abstract]   [Full Text] [Related]  

  • 42. Protective protein/cathepsin A rescues N-glycosylation defects in neuraminidase-1.
    Wang D; Zaitsev S; Taylor G; d'Azzo A; Bonten E
    Biochim Biophys Acta; 2009 Apr; 1790(4):275-82. PubMed ID: 19714866
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sialidoses.
    Franceschetti S; Canafoglia L
    Epileptic Disord; 2016 Sep; 18(S2):89-93. PubMed ID: 27621198
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sialidosis type II: Expansion of phenotypic spectrum and identification of a common mutation in seven patients.
    Arora V; Setia N; Dalal A; Vanaja MC; Gupta D; Razdan T; Phadke SR; Saxena R; Rohtagi A; Verma IC; Puri RD
    Mol Genet Metab Rep; 2020 Mar; 22():100561. PubMed ID: 31956508
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Severe dilated cardiomyopathy as an unusual clinical presentation in an infant with sialidosis type II.
    Eyskens M; Bruyndonckx L; Van Kuilenburg ABP; Eyskens F
    JIMD Rep; 2023 Mar; 64(2):156-160. PubMed ID: 36873090
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optical coherence tomography features in a case of Type I sialidosis.
    Wang IH; Lin TY; Kao ST
    Taiwan J Ophthalmol; 2017; 7(2):108-111. PubMed ID: 29018767
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiovascular involvement in alpha-n-acetyl neuraminidase deficiency syndromes (sialidosis type I and II).
    Prasanna P; Sriram CS; Rodriguez SH; Kohli U
    Cardiol Young; 2021 May; 31(5):862-864. PubMed ID: 33507140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AAV-mediated gene therapy for sialidosis.
    van de Vlekkert D; Hu H; Weesner JA; Fremuth LE; Brown SA; Lu M; Gomero E; Campos Y; Sheppard H; d'Azzo A
    Mol Ther; 2024 Jul; 32(7):2094-2112. PubMed ID: 38796704
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Electrophysiological studies of myoclonus in sialidosis type 2.
    Tobimatsu S; Fukui R; Shibasaki H; Kato M; Kuroiwa Y
    Electroencephalogr Clin Neurophysiol; 1985 Jan; 60(1):16-22. PubMed ID: 2578348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Case of Type 2 Sialidosis With Deletion of a Single Nucleotide at Position c.947 of the Neuraminidase 1 (NEU1) Gene.
    Hassan M; Alharbi MA; Alhassani RY; Hussain AA; Kamfar RY
    Cureus; 2021 Dec; 13(12):e20389. PubMed ID: 35036219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sialidosis type 1 without cherry-red spots: a case report and literature review.
    Zhang C; Liao Z; Zhou Y; Su X
    BMJ Neurol Open; 2024; 6(1):e000498. PubMed ID: 38361966
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short-term, high dose enzyme replacement therapy in sialidosis mice.
    Wang D; Bonten EJ; Yogalingam G; Mann L; d'Azzo A
    Mol Genet Metab; 2005 Jul; 85(3):181-9. PubMed ID: 15979029
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sialidosis type I: ophthalmological findings.
    Sobral I; Cachulo Mda L; Figueira J; Silva R
    BMJ Case Rep; 2014 Oct; 2014():. PubMed ID: 25323282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical presentation of congenital sialidosis in a patient with a neuraminidase gene frameshift mutation.
    Buchholz T; Molitor G; Lukong KE; Praun M; Genzel-Boroviczény O; Freund M; Pshezhetsky AV; Schulze A
    Eur J Pediatr; 2001 Jan; 160(1):26-30. PubMed ID: 11195014
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Exome Sequencing Enables Congenital Sialidosis Type II Diagnosis in Two Siblings Presenting with Unreported Clinical Features from a Rare Homozygous Sequence Variant p.(Tyr370Cys) in
    Flores-Contreras EA; García-Ortiz JE; Robles-Espinoza CD; Zomosa-Signoret V; Becerra-Solano LE; Vidaltamayo R; Castaneda-García C; Esparza-García E; Molina-Aguilar C; Hernández-Orozco AA; Córdova-Fletes C
    Mol Syndromol; 2021 Jul; 12(4):250-257. PubMed ID: 34421504
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NEU1 mutation in a Korean infant with type 2 sialidosis presenting as isolated fetal ascites.
    Lee YJ; Son SK; Park JH; Song JS; Cheon CK
    Pediatr Neonatol; 2015 Feb; 56(1):68-9. PubMed ID: 25223955
    [No Abstract]   [Full Text] [Related]  

  • 57. Neu4, a novel human lysosomal lumen sialidase, confers normal phenotype to sialidosis and galactosialidosis cells.
    Seyrantepe V; Landry K; Trudel S; Hassan JA; Morales CR; Pshezhetsky AV
    J Biol Chem; 2004 Aug; 279(35):37021-9. PubMed ID: 15213228
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis.
    Pshezhetsky AV; Richard C; Michaud L; Igdoura S; Wang S; Elsliger MA; Qu J; Leclerc D; Gravel R; Dallaire L; Potier M
    Nat Genet; 1997 Mar; 15(3):316-20. PubMed ID: 9054950
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Two siblings with adult-onset sialidosis type I (cherry-red spot-myoclonus syndrome)].
    Tana T; Komine Y; Kanzato N; Kawazoe N; Fukiyama K
    Rinsho Shinkeigaku; 1995 Jul; 35(7):803-5. PubMed ID: 8777807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical variability of type II sialidosis by C808T mutation.
    Rodríguez Criado G; Pshezhetsky AV; Rodríguez Becerra A; Gómez de Terreros I
    Am J Med Genet A; 2003 Feb; 116A(4):368-71. PubMed ID: 12522793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.